Rare diseases
Investigational molecules
Locations
Back to Slovakia20 clinical trials in Levice, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Study of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD
SlovakiaStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
SlovakiaStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
SlovakiaA Study of Zenagamtide in Adults With Overweight or Obesity and Type 2 Diabetes
SlovakiaStudy of Tezepelumab Compared to Placebo in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
SlovakiaSlovakiaStudy of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)
SlovakiaStudy of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels
SlovakiaStudy on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
SlovakiaStudy on the Effects of Atuliflapon in Adults with Moderate to Severe Uncontrolled Asthma
SlovakiaComparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma
SlovakiaA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
In Levice, cardiovascular disease research focuses on preventing serious events such as stroke, heart attack, and other vascular complications. These studies are designed to assess new options for stroke prevention, atherosclerotic cardiovascular disease, and related risk reduction.
The trials are mainly evaluating whether new treatments can improve protection against major cardiovascular events and support better long-term outcomes.
A large share of the clinical research in Levice is centered on asthma and chronic obstructive pulmonary disease. These studies explore ways to improve breathing control, reduce flare-ups, and slow the decline in lung function in people with persistent respiratory symptoms.
Overall, the research is aimed at testing new therapies and combination treatments that may help people breathe more easily and stay stable for longer.
Clinical trials in this area examine overweight, obesity, type 2 diabetes, and hyperlipidemia. The goal is to better understand treatment approaches that may support weight reduction and improve metabolic health.
These studies are mainly testing whether newer therapies can improve key health markers and reduce the burden of metabolic disease.
Research in skin and connective tissue diseases is represented by studies on chronic spontaneous urticaria. The main purpose is to evaluate treatments that may improve symptom control and provide longer-lasting relief for people with persistent allergic skin disease.
This area adds a focused immunology component to the clinical trial landscape in Levice.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
